Ontology highlight
ABSTRACT:
SUBMITTER: Yang F
PROVIDER: S-EPMC4516202 | biostudies-other | 2015
REPOSITORIES: biostudies-other
Diabetes, metabolic syndrome and obesity : targets and therapy 20150720
For type 2 diabetes mellitus treatment and clinical development, proper evaluation of cardiovascular risk has been required by regulatory agencies (eg, the US Food and Drug Administration) since cardiovascular safety is very important in this patient population. The US Food and Drug Administration issued general guidelines for cardiovascular safety evaluation that outlined the requirements considered adequate for cardiovascular safety evaluation. However, there are multiple options to obtain the ...[more]